Dr. Reddy's Laboratories is a pharmaceutical company. Co.'s segments include: Global Generics, which includes its business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which includes its business of manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which includes its business that focuses on the research and development of differentiated formulations. We show 4 historical shares outstanding datapoints in our RDY shares outstanding history coverage, used to compute RDY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RDY market cap history over the course of time is important for investors
interested in comparing RDY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RDY versus a peer is one thing; comparing
RDY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RDY can fluctuate over the course of history.
With this page we aim to empower investors researching RDY by allowing them to research the RDY market cap history. |
Free RDY Email Alerts:
Video: The Importance of Market Cap
